Squarepoint Ops LLC Oramed Pharmaceuticals Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 54,439 shares of ORMP stock, worth $127,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,439

Previous 83,355 34.69%

Holding current value

$127,931

Previous $203,000 35.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.17 - $2.52 $62,747 - $72,868	-28,916 Reduced 34.69%	54,439 $131,000
Q3 2024 Nov 14, 2024	BUY	$2.21 - $2.63 $3,529 - $4,200	1,597 Added 1.95%	83,355 $203,000
Q2 2024 Aug 14, 2024	SELL	$2.07 - $2.83 $15,249 - $20,848	-7,367 Reduced 8.27%	81,758 $210,000
Q1 2024 May 15, 2024	SELL	$2.18 - $3.58 $61,369 - $100,780	-28,151 Reduced 24.0%	89,125 $260,000
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $142,119 - $213,595	83,111 Added 243.26%	117,276 $270,000
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $72,429 - $152,717	34,165 New	34,165 $122,000
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $431,761 - $1.04 Million	116,065 New	116,065 $532,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $322,956 - $547,724	-39,433 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $511,840 - $1.17 Million	39,433 New	39,433 $563,000
Q1 2021 May 17, 2021	SELL	$4.22 - $11.33 $128,401 - $344,737	-30,427 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.48 - $4.64 $75,458 - $141,181	30,427 New	30,427 $129,000
Q4 2018 Feb 14, 2019	SELL	$3.0 - $4.94 $43,500 - $71,630	-14,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.64 - $7.11 $67,280 - $103,095	14,500 New	14,500 $71,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

8.11M

Call Options Held

17.4K

Put Options Held

19.5K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $91.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Oramed Pharmaceuticals Inc. Transaction History